Thesis Care, an AI-powered care team platform focused on expanding clinical capacity, announced it has raised $45 million in Series A funding, bringing its total funding to $60 million. The round was led by Oak HC/FT with participation from CRV, Black Opal Ventures, and healthcare technology angel investors.
Alongside the funding, the company revealed its rebrand from Trovo Health to Thesis Care, reflecting the evolution of its platform. Thesis combines AI agents with expert clinicians to manage complex clinical workflows and care management tasks for healthcare organizations.
The platform is designed to understand clinical context, enabling personalized patient engagement and execution of workflows from start to finish. It integrates into existing healthcare operations without requiring providers or staff to adopt new tools, while leveraging human clinicians when needed to ensure accuracy and quality.
Thesis Care has already established partnerships with large provider organizations across primary and specialty care, including U.S. Heart & Vascular, Essen Health Care, Springfield Clinic, Unio Health Partners, and Allied Digestive Health. The company is now expanding into health systems and health plan care teams.
The newly raised capital will be used to accelerate commercial growth, enhance the company’s unified technology platform, and expand its suite of AI-powered care team agents.
Founded in 2024 and headquartered in New York, Thesis Care is positioning itself as infrastructure for scalable care delivery by combining automation with human clinical expertise.
KEY QUOTES
“2025 was a defining year for Thesis as we moved from design partnerships into a clear commercial trajectory and growing customer base. We’ve proven that we can extend clinical capacity and allow our customers to do more for patients at a scale that has historically been impossible. Now, we’re ready to bring that to every healthcare organization that needs it.”
Niren Gandra, M.D., CEO And Co-Founder, Thesis Care
“Thesis lets us deliver better care at scale – without the operational lift you’d expect. It takes real work off our staff’s plates, patients show up prepared, and care gaps get closed. What sets Thesis apart is the human care team behind the agents – that combination of automation and human judgment is what takes patient care to another level. The ROI speaks for itself.”
Shaivali Shah, SVP Of Operations, Allied Digestive Health
“As we scale USHV, we look for partners who can deliver on innovation and execution. Thesis’s combination of AI agents and care team experts allowed us to deploy solutions quickly with minimal internal lift, resulting in a tangible reduction in administrative burden and strengthened practice support.”
Mike Plantz, Senior Vice President Of Revenue Operations, U.S. Heart & Vascular
“Thesis has developed a fundamentally unique platform that addresses clinically deep, complex workflows. We are proud to continue our partnership with the Thesis team as they build the infrastructure for the future of scalable care delivery.”
Andrew Adams, Co-Founder And Managing Partner, Oak HC/FT
